John Paulson Bausch Health Companies Inc. Transaction History
Paulson & Co. Inc.
- $1.3 Billion
- Q2 2024
A detailed history of John Paulson (Paulson & Co. Inc.) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Paulson & Co. Inc. holds 26,439,035 shares of BHC stock, worth $217 Million. This represents 14.13% of its overall portfolio holdings.
Number of Shares
26,439,035
Previous 26,439,035
-0.0%
Holding current value
$217 Million
Previous $281 Million
34.31%
% of portfolio
14.13%
Previous 20.29%
Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
272Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$285 Million2.24% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$184 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$159 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$128 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$107 Million0.27% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.97B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...